Aberrant expression of DNMT1 is correlated with progression and prognosis of various cancers, such as lung cancer [12], hepatocellular carcinoma [13], pancreatic cancer [14], and bladder cancer [15]. The gene discussed is DNMT1; the disease is cancer.